Pearlman Robert B MD Riverside, IL - 60546

Pearlman Robert B MD is categorized under Family Practice Doctors in Riverside, IL and active since 2010.

Pearlman Robert B MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Robert Pearlman at the company’s single location by writing to 3722 Harlem Avenue # Ll10, Riverside, Illinois IL 60546 or by phoning (708) 442-0797. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pearlman Robert B MD
Contact Person: Robert Pearlman
Address: 3722 Harlem Avenue # Ll10, Riverside, Illinois 60546
Phone Number: (708) 442-0797
Website Address: chicagolandretinal.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Pearlman Robert B MD was started in 2010 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Robert Pearlman for inquiries that concern Pearlman Robert B MD by calling the company number (708) 442-0797, as your correspondence is most welcome. Additionally, the physical location of the single location of Pearlman Robert B MD can be found at the coordinates 41.82381,-87.80271 as well as the street address 3722 Harlem Avenue # Ll10 in Riverside, Illinois 60546.

For its online presence, you may visit Pearlman Robert B MD’s website at chicagolandretinal.com and engage with its social media outlets through on Twitter and on Facebook.